Saltar al contenido

Feeding the Mind: Metabolism in Psychiatry with David T. Liebers, MD, MPhil, MPP

11 de agosto de 2026 · 1 h 13 min

Notas del episodio

Dr. David T. Liebers, MD, MPhil, MPP, a research assistant professor of psychiatry at the NYU Grossman School of Medicine and a research psychiatrist at the Nathan Kline Institute, joins Dr. Ben Everett to explore metabolic psychiatry: the growing evidence linking mitochondrial function, bioenergetics, and whole-body metabolism to psychiatric illness. Building on a previous conversation about GLP-1 receptor agonists, this episode broadens the lens to ketogenic diet interventions, SGLT2 inhibitors, and metformin, tracing how each may support brain energetics in depression, schizophrenia, and bipolar disorder.

This conversation arrives as clinicians increasingly confront the metabolic burden of antipsychotic treatment alongside a widening evidence base for interventions originally developed for diabetes and heart failure. Dr. Liebers discusses recent trial data on ketogenic diets in serious mental illness, the mechanistic case for SGLT2 inhibitors as a psychiatric tool, expanding guidelines for metformin co-prescription, and why brain energetics may represent a legitimate and increasingly tractable therapeutic target, not a replacement for existing models of psychiatric illness, but an additional clinical perspective.

🎯 KEY EPISODE HIGHLIGHTS:

🏛️ THE “ERA OF FOOD AS MEDICINE” ISN’T NEW [12:30]

“We have now entered the era of food as medicine.”

Dr. Liebers traces today's food-as-medicine rhetoric back through nearly two centuries of psychiatric interest in diet's role in mental illness.

🧬 MITOCHONDRIAL DYSFUNCTION AS A TREATMENT TARGET [23:30]

“The big challenge, I think, is identifying those interventions that can reliably improve, metabolic function in a way that can be measured and is suitable for randomized trial designs that let us talk about causation.”

Dr. Liebers frames abnormal brain bioenergetics as a specific, measurable target for a subset of patients underserved by monoamine-based treatments.

⚖️ METFORMIN IS DRAMATICALLY UNDERUSED [55:30]

“I think ten to fifteen percent of the people that should be or would qualify under the new guidelines to get metformin are actually on it.”

Despite expanded 2025 consensus guidelines, Dr. Liebers' EHR data suggest most eligible patients are still not receiving metformin for antipsychotic-associated weight gain.

CHAPTERS:

00:00 – Introduction: Building on the GLP-1 Conversation

02:30 – An Unconventional Path to Metabolic Psychiatry

10:30 – Diet in the Asylum Era: A History of Food as Medicine

18:00 – Why Metabolism Returned to Scientific View

23:30 – Imaging Brain Energetics: Bridging Peripheral and Central Metabolism

28:30 – The Stanford Pilot Trial and the Abrams Follow-On RCT

36:00 – Adherence, Meal Delivery, and the Path to GLP-1s

39:30 – GLP-1 Receptor Agonists in Psychiatric Practice

41:30 – Discovering SGLT2 Inhibitors: A Resident's Chance Encounter

45:00 – The Ketogenic Mechanism Behind SGLT2 Inhibition

49:30 – Trial Emulation and the Empagliflozin Pilot Study

52:00 – Metformin's Expanding Role in Antipsychotic-Associated Weight Gain

56:30 – SGLT2 Inhibitors as a Complement to Ketogenic Therapy

61:30 – Toward a Whole-Person Model: Diet, Drugs, and Exercise

66:00 – Confronting the Treatment Gap: Underused Medications

68:00 – The Future of Metabolic Psychiatry: Integration, Not Revolution

71:30 – Closing Thoughts and Sign-Off

LINKS:

Full transcript and show notes:

https://www.psychiatrist.com/jcp/ep20-feeding-mind-metabolism-psychiatry-david-t-liebers/

Journal of Clinical Psychiatry

https://www.psychiatrist.com/jcp/

Publisher of peer-reviewed research discussed in this episode.

Dr. David T. Liebers – LinkedIn

https://www.linkedin.com/in/david-liebers-7b9706169/

Metabolic Mind

https://www.metabolicmind.org/

Patient and clinician resource on ketogenic and metabolic therapies for mental illness, recommended by Dr. Liebers in this episode.

The Emerging Role of GLP-1s in Psychiatry with Roger S. McIntyre, MD, FRCPC

Listen to a previous episode from April 21, 2026 covering GLP-1s in Psychiatry

#MetabolicPsychiatry #KetogenicDiet #SGLT2Inhibitors #Metformin #Mitochondria

Todos los episodios de The Journal of Clinical Psychiatry Podcast

Ajustes

Visualización

Idioma

Determina qué emisoras ves primero en la página de inicio.

Historial

Las emisoras y episodios escuchados recientemente y tus últimas búsquedas solo se guardan en este navegador.

Avisos

Un breve aviso cuando un pódcast que sigues tiene un episodio nuevo. Puedes desactivar pódcast concretos con la campana de su página.

Cuenta

Guarda tus favoritos: en la app y en la web.

Atajos de teclado

/
Abrir búsqueda
Espacio
Reproducir o pausar
← →
En el reproductor: 15 s atrás, 30 s adelante (episodios) · en una fila: siguiente tarjeta
↑ ↓
En una fila: destino dentro de la tarjeta
Inicio / Fin
En una fila: primera o última tarjeta
Esc
Cerrar ventana o menú
?
Este resumen
Reproduciendo ahora

Ir a la emisora

A continuación

    Añade episodios con «A continuación»: sonarán después del episodio actual.